INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,337 | -3.0% | 171,801 | -18.9% | 0.00% | 0.0% |
| Q2 2023 | $4,471 | -72.0% | 211,916 | -77.4% | 0.00% | -57.1% |
| Q1 2023 | $15,975 | -15.4% | 936,940 | -0.9% | 0.01% | -12.5% |
| Q4 2022 | $18,888 | -99.8% | 945,397 | +122.9% | 0.01% | -20.0% |
| Q3 2022 | $9,134,000 | +27.6% | 424,051 | +16.8% | 0.01% | +150.0% |
| Q2 2022 | $7,160,000 | +1290.3% | 363,072 | +1557.3% | 0.00% | – |
| Q1 2022 | $515,000 | -93.4% | 21,908 | -92.4% | 0.00% | -100.0% |
| Q4 2021 | $7,810,000 | +238.5% | 286,710 | +242.2% | 0.00% | 0.0% |
| Q3 2021 | $2,307,000 | +488.5% | 83,791 | +508.9% | 0.00% | – |
| Q2 2021 | $392,000 | -92.4% | 13,762 | -90.9% | 0.00% | -100.0% |
| Q1 2021 | $5,170,000 | +18.9% | 151,777 | +16.2% | 0.00% | +50.0% |
| Q4 2020 | $4,348,000 | -28.7% | 130,592 | -31.1% | 0.00% | -50.0% |
| Q3 2020 | $6,094,000 | +37.1% | 189,591 | +17.5% | 0.00% | +33.3% |
| Q2 2020 | $4,446,000 | +107.5% | 161,392 | +20.8% | 0.00% | +50.0% |
| Q1 2020 | $2,143,000 | -85.2% | 133,577 | -78.0% | 0.00% | -75.0% |
| Q4 2019 | $14,496,000 | +1059.7% | 607,040 | +755.8% | 0.01% | +700.0% |
| Q3 2019 | $1,250,000 | -18.0% | 70,931 | +19.2% | 0.00% | 0.0% |
| Q2 2019 | $1,524,000 | -76.5% | 59,512 | -73.3% | 0.00% | -75.0% |
| Q1 2019 | $6,477,000 | +370.0% | 222,785 | +112.1% | 0.00% | +300.0% |
| Q4 2018 | $1,378,000 | +87.7% | 105,030 | +189.5% | 0.00% | 0.0% |
| Q3 2018 | $734,000 | +3.5% | 36,281 | +21.0% | 0.00% | 0.0% |
| Q2 2018 | $709,000 | -21.0% | 29,986 | -24.8% | 0.00% | 0.0% |
| Q1 2018 | $898,000 | +5.3% | 39,865 | +45.7% | 0.00% | 0.0% |
| Q4 2017 | $853,000 | -88.4% | 27,361 | -88.3% | 0.00% | -87.5% |
| Q3 2017 | $7,323,000 | +3837.1% | 234,604 | +2056.7% | 0.01% | – |
| Q2 2017 | $186,000 | +181.8% | 10,878 | +183.8% | 0.00% | – |
| Q1 2017 | $66,000 | +26.9% | 3,833 | -2.0% | 0.00% | – |
| Q4 2016 | $52,000 | +26.8% | 3,912 | +41.0% | 0.00% | – |
| Q3 2016 | $41,000 | +17.1% | 2,775 | -5.0% | 0.00% | – |
| Q1 2016 | $35,000 | +118.8% | 2,920 | +227.4% | 0.00% | – |
| Q4 2015 | $16,000 | -94.7% | 892 | -94.7% | 0.00% | – |
| Q3 2015 | $302,000 | +941.4% | 16,737 | +1276.4% | 0.00% | – |
| Q2 2015 | $29,000 | -35.6% | 1,216 | -46.3% | 0.00% | – |
| Q1 2015 | $45,000 | -33.8% | 2,263 | -50.0% | 0.00% | – |
| Q4 2014 | $68,000 | +209.1% | 4,522 | +165.4% | 0.00% | – |
| Q3 2014 | $22,000 | -99.2% | 1,704 | -98.9% | 0.00% | -100.0% |
| Q2 2014 | $2,933,000 | -83.7% | 154,388 | -83.7% | 0.00% | -85.0% |
| Q1 2014 | $17,992,000 | +16873.6% | 946,902 | +15096.6% | 0.02% | – |
| Q4 2013 | $106,000 | -7.8% | 6,231 | -18.4% | 0.00% | – |
| Q3 2013 | $115,000 | +538.9% | 7,632 | +415.0% | 0.00% | – |
| Q2 2013 | $18,000 | – | 1,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |